James W. Vardiman

James W. Vardiman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James W. Vardiman sits on this spectrum.

James W. Vardiman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James W. Vardiman sits on this spectrum.

Overview

Best Publications

• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

  Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele

  9969
  Citations

• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

  James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning

  6008
  Citations

• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  Nancy Lee Harris;Elaine S. Jaffe;Jacques Diebold;Georges Flandrin

  5442
  Citations

• The World Health Organization (WHO) classification of the myeloid neoplasms.

  James W. Vardiman;Nancy Lee Harris;Richard D. Brunning

  3139
  Citations

• Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

  A Tefferi;J W Vardiman

  1398
  Citations

• Diagnostic criteria and classification of mastocytosis: a consensus proposal

  Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley

  1338
  Citations

• The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997

  N. L. Harris;E. S. Jaffe;J. Diebold;G. Flandrin

  1170
  Citations

• Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

  M M Le Beau;K S Albain;R A Larson;J W Vardiman

  977
  Citations

• Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

  Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  907
  Citations

• Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study

  Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus

  905
  Citations

• Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

  Peter Paschka;Guido Marcucci;Amy S. Ruppert;Krzysztof Mrózek

  837
  Citations

• Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

  John C. Byrd;Bercedis L. Peterson;Vicki A. Morrison;Kathleen Park

  836
  Citations

• Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

  Sonali M. Smith;Michelle M. Le Beau;Dezheng Huo;Theodore Karrison

  776
  Citations

• Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association

  M M Le Beau;R A Larson;M A Bitter;J W Vardiman

  696
  Citations

• What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.

  Wendy Stock;Mei La;Ben Sanford;Clara D. Bloomfield

  687
  Citations

• Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease

  Janet D. Rowley;Harvey M. Golomb;James W. Vardiman

  654
  Citations

• Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia

  Richard A Larson;Koji Kondo;James W Vardiman;Ann E Butler

  596
  Citations

• The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

  N L Harris;E S Jaffe;J Diebold;G Flandrin

  575
  Citations

• The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

  N L Harris;E S Jaffe;J Diebold;G Flandrin

  544
  Citations

• The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

  N L Harris;E S Jaffe;J Diebold;G Flandrin

  465
  Citations